Literature DB >> 23001041

NEDDylation controls the target specificity of E2F1 and apoptosis induction.

I Aoki1, M Higuchi, Y Gotoh.   

Abstract

The transcription factor E2F1 has pivotal roles in both cell proliferation and cell death, and is an important molecular target in cancer. Under proliferative conditions E2F1 induces the expression of genes that promote cell cycle progression, such as E2F2, whereas under proapoptotic conditions E2F1 induces expression of genes such as p73 that lead to apoptosis. The mechanism by which the apoptotic function of E2F1 is activated remains unclear, however. We now show that members of the E2F family are covalently conjugated with the ubiquitin-like modifier NEDD8. Overexpression of SENP8, a NEDD8-specific cysteine protease, resulted in deNEDDylation of E2F1 and promoted its transactivation activity at the p73 gene but not at the E2F2 gene. Knockdown of SENP8, on the other hand, attenuated p73 expression and apoptosis induced by E2F1 or by DNA damage. SENP8 also promoted the interaction between E2F1 and its cofactor Microcephalin 1, which is required for p73 induction. These results suggest that NEDDylation is a molecular trigger that modifies the target specificity of E2F1, and could have important implications for E2F1 regulation of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001041     DOI: 10.1038/onc.2012.428

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.

Authors:  Hongjun Lv; Rui Liu; Jiao Fu; Qi Yang; Jing Shi; Pu Chen; Meiju Ji; Bingyin Shi; Peng Hou
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  Neddylation controls basal MKK7 kinase activity in breast cancer cells.

Authors:  T Zhu; J Wang; Y Pei; Q Wang; Y Wu; G Qiu; D Zhang; M Lv; W Li; J Zhang
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

3.  Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1-Deficient Human and Mouse Small-Cell Lung Cancer.

Authors:  Hongling Zhao; Niloy J Iqbal; Vineeth Sukrithan; Cari Nicholas; Yingjiao Xue; Cindy Yu; Joseph Locker; Juntao Zou; Edward L Schwartz; Liang Zhu
Journal:  Cancer Res       Date:  2020-04-07       Impact factor: 12.701

Review 4.  Neddylation and deneddylation in cardiac biology.

Authors:  Sridhar Kandala; Il-Man Kim; Huabo Su
Journal:  Am J Cardiovasc Dis       Date:  2014-12-29

Review 5.  Protein neddylation: beyond cullin-RING ligases.

Authors:  Radoslav I Enchev; Brenda A Schulman; Matthias Peter
Journal:  Nat Rev Mol Cell Biol       Date:  2015-01       Impact factor: 94.444

Review 6.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Authors:  Lifang Zhang; Jianhong Wu; Ming Tat Ling; Liang Zhao; Kong-Nan Zhao
Journal:  Mol Cancer       Date:  2015-04-17       Impact factor: 27.401

Review 7.  The NEDD8 modification pathway in plants.

Authors:  Julia Mergner; Claus Schwechheimer
Journal:  Front Plant Sci       Date:  2014-03-21       Impact factor: 5.753

8.  Topographical transcriptome mapping of the mouse medial ganglionic eminence by spatially resolved RNA-seq.

Authors:  Sabrina Zechel; Pawel Zajac; Peter Lönnerberg; Carlos F Ibáñez; Sten Linnarsson
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  Myeloma overexpressed 2 (Myeov2) regulates L11 subnuclear localization through Nedd8 modification.

Authors:  Manato Ebina; Fuminori Tsuruta; Megumi C Katoh; Yu Kigoshi; Akie Someya; Tomoki Chiba
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

10.  CACUL1/CAC1 Regulates the Antioxidant Response by Stabilizing Nrf2.

Authors:  Yu Kigoshi; Tomomi Fukuda; Tomoyuki Endo; Nami Hayasaka; Shun-ichiro Iemura; Toru Natsume; Fuminori Tsuruta; Tomoki Chiba
Journal:  Sci Rep       Date:  2015-08-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.